TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
TRDA

Entrada Therapeutics Inc

Healthcare · Biotechnology · —

6.60$ -1.6% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TRDA
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
95.6% 91.8% 97.7% 83.3% 78.8% 83.6% 81.2%
92.4% 89.7% 95.2% 17.9% 14.4% 19.2% 24.0%
92.4% 89.7% 95.2% 74.9% 75.0% 79.8% 78.4%
0.3% 1.3% 0.7% 0.7%
0.0%
4.4% 7.0% 2.0% 13.1%
185.1% 195.3% 2.3% 15.7% 48.3% 18.6% 18.9%
10.5% 7.7% 2.2% 8.7% 33.8% 7.5% 6.5%
3.3% 1.7% 1.4% 1.1%
3.9% 3.7% 0.2% 2.4% 0.7% 0.8% 0.6%
-85.1% -95.3% 97.7% 84.3% 51.7% 81.4% 81.1%
-87.7% -97.7% -30.6% -74.7% -41.6% -24.6% -72.4%
5.7% 71.8% 10.2% 12.4% 7.0% 7.4% 11.0%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?